Patents by Inventor Julie Clarke

Julie Clarke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METABOLITES FOR TREATMENT AND PREVENTION OF AUTOIMMUNE DISEASE
    Publication number: 20210244692
    Abstract: The present invention relates to methods for treating or preventing or delaying the progression or onset of autoimmune disease, comprising the use of dietary metabolites.
    Type: Application
    Filed: February 17, 2021
    Publication date: August 12, 2021
    Applicants: MONASH UNIVERSITY, COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
    Inventors: CHARLES REAY MACKAY, Eliana Marino Moreno, Trevor Lockett, Julie Clarke, David Topping
  • METABOLITES FOR TREATMENT AND PREVENTION OF AUTOIMMUNE DISEASE
    Publication number: 20190167615
    Abstract: The present invention relates to methods for treating or preventing or delaying the progression or onset of autoimmune disease, providing dietary metabolites comprising a combination of two or more short chain fatty acids, esters or salts thereof. The present invention also provides compositions for treating, preventing or delaying the progression of, or onset of autoimmune disease.
    Type: Application
    Filed: August 10, 2017
    Publication date: June 6, 2019
    Applicants: MONASH UNIVERSITY, COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH OR
    Inventors: Charles REAY MACKAY, Eliana Marino MORENO, Trevor LOCKETT, Julie CLARKE, David TOPPING
  • Colon cancer gene expression signatures and methods of use
    Patent number: 10196691
    Abstract: A gene expression signature of colon cancer, microarrays including them and methods of using the colon gene expression signature are provided. The gene expression signature is especially useful for determining the prognosis of a patient diagnosed with colon cancer, such as stage II colon cancer. The gene signature described herein is also useful for determining effectiveness of surgical resection with or without adjuvant chemotherapy, and determining possibility of cancer recurrence in patients with colon cancer.
    Type: Grant
    Filed: January 25, 2012
    Date of Patent: February 5, 2019
    Assignee: ALMAC DIAGNOSTICS LIMITED
    Inventors: Denis Paul Harkin, Vitali Proutski, Julie Clarke, Peter Kerr, Richard Kennedy, Andreas Winter, Timothy Davison, Max Bylesjo, Vadim Farztdinov, Claire Trinder, Robert James Holt